Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia

Background: Nosocomial pneumonia (NP) due to multidrug-resistant (MDR) Gram-negative pathogens, has continued to rise over the last several decades. Parenteral administration of colistin results in poor alveolar penetration and subtherapeutic concentration; therefore, direct drug deposition at site...

Descripció completa

Dades bibliogràfiques

Autors principals:	Thamer A. Almangour, Basel Alenazi, Leen Ghonem, Abdullah A. Alhifany, Bassam A. Aldakheel, Alya Alruwaili
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2020-08-01
Col·lecció:	Saudi Pharmaceutical Journal
Matèries:	Inhaled colistin Nosocomial pneumonia Gram-negative bacteria
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1319016420301493
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!